Mitochondria in Alzheimer disease : regulatory mechanisms and cell death
Author: Hedskog, Louise
Date: 2012-09-14
Location: Hörsalen, Novum Plan 4, Huddinge
Time: 09.00
Department: Inst för neurobiologi, vårdvetenskap och samhälle / Dept of Neurobiology, Care Sciences and Society
Abstract
Synaptic loss is the major correlate for cognitive decline in Alzheimer disease (AD). Processes taking place in the synapses are highly energy demanding and needs strict regulation, which makes the mitochondria and ER crucial at these sites so as to supply energy and spatially regulate intracellular calcium signaling. The ER and mitochondria interact with each other at a highly specialized region of ER called the mitochondria-associated ER membrane (MAM). At the MAM several processes are regulated, including calcium handling, metabolism of glucose, phospholipids and cholesterol as well as apoptosis, all of which are deranged in AD.
The aim of this thesis was to obtain deeper understanding of processes that could be behind mitochondrial dysfunction and caspase activation, and thereby cause synapse loss. Caspases are activated both during normal plasticity and in apoptosis, and their activation is associated with elevated Aβ production.
In Paper I, we studied this relationship and showed that during caspase activation intracellular Aβ42/Aβ40 ratio increases due to caspase cleavage of presenilin 1 (PS1) residing in active γ-secretase complexes. Intracellular Aβ is cytotoxic and interferes with various processes for example intra-mitochondrial accumulation cause damage to mitochondrial functions. Aβ is imported into the mitochondria via the TOM40 pore. A specific polymorphic poly-T variant (rs10524523), in the TOMM40 gene had been postulated to cause earlier disease onset of late-onset AD (LOAD) in APOE ε3/ε4 carriers.
Knowing the importance of TOM40 protein we set out, in Paper II, to investigate the functional implication of this polymorphism. However, we could not identify any deficits in mitochondrial function or morphology. Nevertheless, the mitochondria are evidently affected by AD, as indication include altered calcium homeostasis and metabolism. These alterations can be linked to the MAM region, which is a region scarcely investigated in the brain.
Therefore, in Paper III, studying MAM, we showed that it exists in synapses and is essential for both neuronal and astrocytic survival. Furthermore, we showed that MAM is altered in human AD brain as well as in APPSwe/Lon mice, and is so before the appearance of plaques. Moreover, MAM can be functionally modulated by the amyloid-β peptide (Aβ). Based on evident alterations in mitochondrial function in AD, treatments enhancing mitochondrial resistance could be a promising strategy.
The final study, Paper IV, concerned a potential novel drug, Dimebon (Latrepirdine), intended for treatment of AD. We found it to enhance mitochondrial function both in absence and presence of stress, and, in turn, partially protect cells to maintain cell viability. Since mitochondrial function is essential for synaptic integrity drugs targeting the mitochondria could have disease-modifying effect.
The aim of this thesis was to obtain deeper understanding of processes that could be behind mitochondrial dysfunction and caspase activation, and thereby cause synapse loss. Caspases are activated both during normal plasticity and in apoptosis, and their activation is associated with elevated Aβ production.
In Paper I, we studied this relationship and showed that during caspase activation intracellular Aβ42/Aβ40 ratio increases due to caspase cleavage of presenilin 1 (PS1) residing in active γ-secretase complexes. Intracellular Aβ is cytotoxic and interferes with various processes for example intra-mitochondrial accumulation cause damage to mitochondrial functions. Aβ is imported into the mitochondria via the TOM40 pore. A specific polymorphic poly-T variant (rs10524523), in the TOMM40 gene had been postulated to cause earlier disease onset of late-onset AD (LOAD) in APOE ε3/ε4 carriers.
Knowing the importance of TOM40 protein we set out, in Paper II, to investigate the functional implication of this polymorphism. However, we could not identify any deficits in mitochondrial function or morphology. Nevertheless, the mitochondria are evidently affected by AD, as indication include altered calcium homeostasis and metabolism. These alterations can be linked to the MAM region, which is a region scarcely investigated in the brain.
Therefore, in Paper III, studying MAM, we showed that it exists in synapses and is essential for both neuronal and astrocytic survival. Furthermore, we showed that MAM is altered in human AD brain as well as in APPSwe/Lon mice, and is so before the appearance of plaques. Moreover, MAM can be functionally modulated by the amyloid-β peptide (Aβ). Based on evident alterations in mitochondrial function in AD, treatments enhancing mitochondrial resistance could be a promising strategy.
The final study, Paper IV, concerned a potential novel drug, Dimebon (Latrepirdine), intended for treatment of AD. We found it to enhance mitochondrial function both in absence and presence of stress, and, in turn, partially protect cells to maintain cell viability. Since mitochondrial function is essential for synaptic integrity drugs targeting the mitochondria could have disease-modifying effect.
List of papers:
I. Louise Hedskog, Camilla A. Hansson Petersen, Annelie I Svensson, Hedvig Welander, Lars O Tjernberg, Helena Karlström, Maria Ankarcrona. γ-Secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Aβ42/Aβ40 Ratio. J Cell Mol Med. Oct 15, 2150-2163 (2011).
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Louise Hedskog, Jesper Brohede, Birgitta Wiehager, Catarina Moreira Pinho, Priya Revathikumar, Lena Lilius, Elzbieta Glaser, Caroline Graff, Helena Karlström, Maria Ankarcrona. Biochemical studies of poly-T variants in the Alzheimer disease associated TOMM40 gene. J Alzheimer Dis. May 16 (2012).
Fulltext (DOI)
Pubmed
III. Louise Hedskog, Catarina Moreira Pinho, Riccardo Filadi, Laura Hertwig, Birgitta Wiehager, Annica Rönnbäck, Sandra Gellhaar, Anna Sandebring, Marie Westerlund, Caroline Graff, Bengt Winblad, Dagmar Galter, Homira Behbahani, Paola Pizzo, Elzbieta Glaser, Maria Ankarcrona. MAM is essential for neuronal survival and modulated by Alzheimer disease pathology. [Submitted]
IV. Shouting Zhang, Louise Hedskog, Camilla A Hansson Petersen, Bengt Winblad, Maria Ankarcrona. Dimebon (Latrepirdine) enhances mitochondrial function and protects neuronal cells from death. J Alzheimers Dis. 21, 389-402 (2010).
Fulltext (DOI)
Pubmed
View record in Web of Science®
I. Louise Hedskog, Camilla A. Hansson Petersen, Annelie I Svensson, Hedvig Welander, Lars O Tjernberg, Helena Karlström, Maria Ankarcrona. γ-Secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Aβ42/Aβ40 Ratio. J Cell Mol Med. Oct 15, 2150-2163 (2011).
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Louise Hedskog, Jesper Brohede, Birgitta Wiehager, Catarina Moreira Pinho, Priya Revathikumar, Lena Lilius, Elzbieta Glaser, Caroline Graff, Helena Karlström, Maria Ankarcrona. Biochemical studies of poly-T variants in the Alzheimer disease associated TOMM40 gene. J Alzheimer Dis. May 16 (2012).
Fulltext (DOI)
Pubmed
III. Louise Hedskog, Catarina Moreira Pinho, Riccardo Filadi, Laura Hertwig, Birgitta Wiehager, Annica Rönnbäck, Sandra Gellhaar, Anna Sandebring, Marie Westerlund, Caroline Graff, Bengt Winblad, Dagmar Galter, Homira Behbahani, Paola Pizzo, Elzbieta Glaser, Maria Ankarcrona. MAM is essential for neuronal survival and modulated by Alzheimer disease pathology. [Submitted]
IV. Shouting Zhang, Louise Hedskog, Camilla A Hansson Petersen, Bengt Winblad, Maria Ankarcrona. Dimebon (Latrepirdine) enhances mitochondrial function and protects neuronal cells from death. J Alzheimers Dis. 21, 389-402 (2010).
Fulltext (DOI)
Pubmed
View record in Web of Science®
Institution: Karolinska Institutet
Supervisor: Ankarcrona, Maria
Issue date: 2012-08-24
Rights:
Publication year: 2012
ISBN: 978-91-7457-854-6
Statistics
Total Visits
Views | |
---|---|
Mitochondria ...(legacy) | 1410 |
Mitochondria ... | 265 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Mitochondria ... | 0 | 2 | 0 | 0 | 0 | 2 | 2 |
File Visits
Views | |
---|---|
Thesis_Louise_Hedskog.pdf(legacy) | 874 |
Spikblad_Louise_Hedskog.pdf(legacy) | 294 |
Thesis_Louise_Hedskog.pdf | 254 |
Spikblad_Louise_Hedskog.pdf | 27 |
Thesis_Louise_Hedskog.pdf.txt(legacy) | 2 |
Spikblad_Louise_Hedskog.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 469 |
Germany | 263 |
Sweden | 137 |
China | 77 |
South Korea | 32 |
Russia | 28 |
Denmark | 24 |
United Kingdom | 21 |
Austria | 14 |
France | 13 |
Top cities views
Views | |
---|---|
Kiez | 81 |
Sunnyvale | 56 |
Ashburn | 51 |
Romeo | 38 |
Stockholm | 38 |
Beijing | 30 |
Seoul | 30 |
Ballerup | 21 |
London | 13 |
New York | 13 |